TrialInvestigational new drugs2011
Phase II study of sunitinib as second-line treatment for advanced gastric cancer.
Yung-Jue Bang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
88 papers cite itlatest 60 shown
this paperpooled ittrialcites it